Delivery Order SPE2DB22D2005-SPE2DB24FJQR0

Award Date 7/26/24
Potential Completion Date 7/29/24
Potential Value $2.5K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $1,487.04 firm fixed-price contract is for the delivery of 4565784452 - dextroamphetamine-amphetamine 10 mg tablets, with a completion date of September 13, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,328.62, is for the delivery of 20mg dextroamphetamine-amphetamine tablets. This order is issued under an Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. The IDC serves as a primary vehicle...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $1,463.99, is for the supply of Dextroamphetamine-Amphetamine 5 mg tablets. The contract has an ultimate completion date of October 16, 2023 and is a firm fixed-price contract. This award is associated with a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA, valued at...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor. The $1,388.90 contract is for the supply of dextroamphetamine-amphetamine 15 mg tablets in 100-count bottles. The award has an ultimate completion date of July 18, 2024 and is not a set-aside. AmerisourceBergen holds an Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued up to $999,999,999, which...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,343.80 firm fixed-price contract is for the delivery of 4560836687 dextroamphetamine-amphetamine 20 mg tablets. The contract has a completion date of May 8, 2023 and is not designated as a set-aside. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of 10 mg dextroamphetamine-amphetamine tablets. The contract has a ceiling value of $2,035.68 and a period of performance ending on July 19, 2024. The contract is a firm-fixed-price delivery order, with no set-aside designation. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical distribution company Amerisourcebergen Corporation. The $3,653.71 order is for the supply of dextroamphetamine-amphetamine 10 mg tablets, to be delivered by January 30, 2024. Amerisourcebergen Drug Corp holds an indefinite delivery contract (IDC) with DLA with a potential value of $999,999,999.00, which serves as the primary vehicle for...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of 5mg dextroamphetamine tablets. The $1,196.65 firm fixed price contract has a performance period through May 2025 and is not set aside. AmerisourceBergen holds a substantial $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, enabling the company to provide a wide range of pharmaceutical and...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Dextroamphetamine-Amphetamine 10 mg tablets, a prescription medication, with a ceiling value of $1,587.02 and a period of performance extending to June 18, 2025. The contract is a Firm Fixed Price Delivery Order, with no set-aside designation, indicating open competition....
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the provision of 4,568,263,370 dextroamphetamine 10 mg tablets in 100-count packages. The contract has a firm fixed price of $1,532.39 and a completion date of May 14, 2025. It is not a set-aside contract, indicating open competition. Amerisourcebergen Drug Corp holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support...
  • SPE2DB22D2005
    Indefinite Delivery Contract
  • SPE2DB22D2005-SPE2DB24FJQR0
    Delivery Order

This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp for the supply of Dextroamphetamine-Amphetamine 10 mg tablets. The fixed-price contract, valued at $2,503.68, has a period of performance through July 29, 2024. Amerisourcebergen, a major pharmaceutical distributor, has been awarded this order as part of its larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, for delivering a range of medical commodities to support military treatment programs. This particular order does not have a set-aside designation.

Generated 10/25/24, 9:26 AM